Jörg Schüpbach
Swiss National Center for Retroviruses
University of Zurich
Gloriastrasse 30
CH-8028 Zurich
Switzerland
Name/email consistency: high
- Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. Schüpbach, J., Tomasik, Z., Knuchel, M., Opravil, M., Günthard, H.F., Nadal, D., Böni, J. J. Med. Virol. (2006)
- HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. Schüpbach, J., Günthard, H., Joos, B., Fischer, M., Böni, J., Tomasik, Z., Yerly, S., Perrin, L., Battegay, M., Furrer, H., Vernazza, P., Bernasconi, E., Hirschel, B. J. Acquir. Immune Defic. Syndr. (2005)
- HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. Schüpbach, J., Böni, J., Bisset, L.R., Tomasik, Z., Fischer, M., Günthard, H.F., Ledergerber, B., Opravil, M. J. Acquir. Immune Defic. Syndr. (2003)
- Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. Schüpbach, J. Int. Arch. Allergy Immunol. (2003)
- Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. Schüpbach, J. AIDS. Rev (2002)
- Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. Schüpbach, J., Böni, J., Flepp, M., Tomasik, Z., Joller, H., Opravil, M. J. Med. Virol. (2001)
- Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Schüpbach, J., Tomasik, Z., Nadal, D., Ledergerber, B., Flepp, M., Opravil, M., Böni, J. Int. J. Antimicrob. Agents (2000)
